Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

NCT06410248 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma, IDH-Wildtype
Recurrent WHO Grade 2 Glioma
Recurrent WHO Grade 3 Glioma
Recurrent WHO Grade 4 Glioma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Magnetic Resonance Imaging
OTHER: Questionnaire Administration
PROCEDURE: Resection
DRUG: Temozolomide
DRUG: Triapine

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]